Decreased monocyte-mediated angiogenesis in scleroderma
- 1 August 1992
- journal article
- Published by Elsevier in Clinical Immunology and Immunopathology
- Vol. 64 (2) , 153-160
- https://doi.org/10.1016/0090-1229(92)90193-r
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Thiol-containing compounds inhibit the production of monocyte/macrophage-derived angiogenic activityInflammation Research, 1991
- Macrophage-induced angiogenesis is mediated by tumour necrosis factor-αNature, 1987
- Human monocyte modulation of endothelial cells and fibroblast growth: Possible mechanism for fibrosisClinical Immunology and Immunopathology, 1986
- Stimulation of neovascularization by human rheumatoid synovial tissue macrophagesArthritis & Rheumatism, 1986
- Induction of Neovascularization by Activated Human MonocytesJournal of Leukocyte Biology, 1986
- Protamine is an inhibitor of angiogenesisNature, 1982
- Widefield capillary microscopy. technique and rating scale for abnormalities seen in scleroderma and related disordersArthritis & Rheumatism, 1981
- Preliminary criteria for the classification of systemic sclerosis (scleroderma)Arthritis & Rheumatism, 1980
- Stimulation of wound blood vessel growth by wound macrophagesJournal of Surgical Research, 1979
- Skin capillary abnormalities as indicators of organ involvement in scleroderma (systemic sclerosis), Raynaud's syndrome and dermatomyositisThe American Journal of Medicine, 1976